EW · Edwards Lifesciences Corp
United States · RS rating 74 · As of 2026-10-14
| Price | 86.45 USD |
|---|---|
| 1-day change | +1.4% |
| RS rating (overall / 1M / 3M / 12M) | 74 / 75 / 57 / 72 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 32 / 32 / 22 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | -68.0% |
| Sales growth Q/Q | +1.1% |
| Distance from 52-week high | +9.2% |
| Market cap (USD) | $46.0B |